Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|28|3054-3067

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.28, 2017-09, pp. : 3054-3067

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase-5 Inhibitors: Future Perspectives

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3540-3551

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutical Relevance of MAP-Kinase Inhibitors in Renal Diseases: Current Knowledge and Future Clinical Perspectives

By  

Current Medicinal Chemistry, Vol. 15, Iss. 20, 2008-08 ,pp. : 2054-2070

Bentham Science Publishers

Access to resources Recommend Favorite

Current Immunotherapy of Multiple Sclerosis and Future Challenges: Relevance of Immune-Mediated Repair

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1409-1417

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Modulation of Gut Microbiota: Current Clinical Applications and Future Perspectives

By  

Current Drug Targets, Vol. 15, Iss. 8, 2014-07 ,pp. : 762-770

Bentham Science Publishers

Access to resources Recommend Favorite

Biologics in Inflammatory Immune-mediated Systemic Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 1008-1016

Bentham Science Publishers

Access to resources Recommend Favorite